» Articles » PMID: 39657103

Stratum Corneum Nanotexture Feature Detection Using Deep Learning and Spatial Analysis: a Noninvasive Tool for Skin Barrier Assessment

Overview
Journal Gigascience
Specialties Biology
Genetics
Date 2024 Dec 10
PMID 39657103
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Corneocyte surface nanoscale topography (nanotexture) has recently emerged as a potential biomarker for inflammatory skin diseases, such as atopic dermatitis (AD). This assessment method involves quantifying circular nano-size objects (CNOs) in corneocyte nanotexture images, enabling noninvasive analysis via stratum corneum (SC) tape stripping. Current approaches for identifying CNOs rely on computer vision techniques with specific geometric criteria, resulting in inaccuracies due to the susceptibility of nano-imaging techniques to environmental noise and structural occlusion on the corneocyte.

Results: This study recruited 45 AD patients and 15 healthy controls, evenly divided into 4 severity groups based on their Eczema Area and Severity Index scores. Subsequently, we collected a dataset of over 1,000 corneocyte nanotexture images using our in-house high-speed dermal atomic force microscope. This dataset was utilized to train state-of-the-art deep learning object detectors for identifying CNOs. Additionally, we implemented a kernel density estimator to analyze the spatial distribution of CNOs, excluding ineffective regions with minimal CNO occurrence, such as ridges and occlusions, thereby enhancing accuracy in density calculations. After fine-tuning, our detection model achieved an overall accuracy of 91.4% in detecting CNOs.

Conclusions: By integrating deep learning object detector with spatial analysis algorithms, we developed a precise methodology for calculating CNO density, termed the Effective Corneocyte Topographical Index (ECTI). The ECTI demonstrated exceptional robustness to nano-imaging artifacts and presents substantial potential for advancing AD diagnostics by effectively distinguishing between SC samples of varying AD severity and healthy controls.

References
1.
Hanifin J, Baghoomian W, Grinich E, Leshem Y, Jacobson M, Simpson E . The Eczema Area and Severity Index-A Practical Guide. Dermatitis. 2022; 33(3):187-192. PMC: 9154300. DOI: 10.1097/DER.0000000000000895. View

2.
Sobek J, Medina Inojosa J, Medina Inojosa B, Rassoulinejad-Mousavi S, Conte G, Lopez-Jimenez F . MedYOLO: A Medical Image Object Detection Framework. J Imaging Inform Med. 2024; 37(6):3208-3216. PMC: 11612059. DOI: 10.1007/s10278-024-01138-2. View

3.
Franz J, Beutel M, Gevers K, Kramer A, Thyssen J, Kezic S . Nanoscale alterations of corneocytes indicate skin disease. Skin Res Technol. 2015; 22(2):174-80. DOI: 10.1111/srt.12247. View

4.
de Boer F, van der Molen H, Kezic S . Epidermal biomarkers of the skin barrier in atopic and contact dermatitis. Contact Dermatitis. 2023; 89(4):221-229. DOI: 10.1111/cod.14391. View

5.
Schmitt J, Langan S, Deckert S, Svensson A, von Kobyletzki L, Thomas K . Assessment of clinical signs of atopic dermatitis: a systematic review and recommendation. J Allergy Clin Immunol. 2013; 132(6):1337-47. DOI: 10.1016/j.jaci.2013.07.008. View